![John L. Palmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John L.
Palmer is a Co-Founder of Enzymatics, Inc. He was a Faculty Member of the Harvard Medical School and the Massachusetts General Hospital Diabetes Unit.
He held various positions at Repligen Corp.
Dr. Palmer holds a PhD.
| Companies | Position | End |
|---|---|---|
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | - |
Verso Technologies, Inc.
 Verso Technologies, Inc. Information Technology ServicesTechnology Services Provides communications network solutions to service providers and enterprises | Chief Administrative Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Verso Technologies, Inc.
Verso Technologies, Inc. Information Technology ServicesTechnology Services Provides communications network solutions to service providers and enterprises | Technology Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Select your edition
All financial news and data tailored to specific country editions
